RESUMO
PURPOSE: Ginseng has been used as a tonic to improve overall health, restore balance in the body, help the body to heal itself, reduce stress, boost energy, and enhance the immune system. The aim of this review was to assess current evidence that ginseng improves sperm quality. MATERIALS AND METHODS: We searched twelve databases (PubMed, EMBASE, AMED, the Cochrane Library, five Korean medical databases, and three Chinese medical databases), using a cut-off date of 1st December 2019. We included clinical studies in which healthy men or men with fertility issues were treated with ginseng. We used Cochrane's risk of bias (ROB) tool to assess the ROB in the studies examined. RESULTS: From two-hundred and nineteen potentially eligible studies, just five relevant studies were selected (two randomized clinical trials [RCTs], one controlled clinical trial [CCT], and two observational studies). Of these studies, one RCT reported some positive results when using Korean red ginseng to improve sperm quality in infertile men. In addition, the other RCT reported that the effects of ginseng on sperm quality were equivalent to those found when valerian tablets are taken by healthy people. One CCT and two uncontrolled observational studies, however, did not demonstrate the clear effectiveness of ginseng in improving sperm quality in infertile men. CONCLUSIONS: Currently, there are few trials investigating the efficacy of ginseng for improving sperm quality. The available studies demonstrate a high ROB. It can be suggested that overall, the evidence regarding ginseng improving sperm quality is limited.
RESUMO
BACKGROUND: The aim of this systematic review is to determine whether ginseng is effective in improving sperm quality. METHODS AND ANALYSIS: Twelve databases will be searched from their inception to the present date: PubMed, EMBASE, AMED, the Cochrane Library, 5 Korean medical databases (KoreaMed, DBpia, OASIS, the Research Information Service System [RISS], and the Korean Studies Information Service System [KISS]), and 3 Chinese medical databases (China National Knowledge Infrastructure [CNKI], the Wanfang Database, and the Chinese Scientific Journals Database [VIP]). We will include all prospective clinical trials including randomized controlled trials (RCTs), controlled trials, and uncontrolled observational studies. We will exclude case study and case series, and retrospective studies in which healthy men or men with subfertility are treated with any type of ginseng. We will exclude studies comparing the 2 different forms of ginseng. The selection of the studies, data abstraction, and validations will be performed independently by 2 researchers. The risk of bias of the RCTs will be evaluated using the Cochrane's risk of bias assessment tool. ETHICS AND DISSEMINATION: The findings will be disseminated to appropriate audiences via peer-reviewed publications and conference presentations. Our review will provide readers the opportunity to access studies originally published in East Asian languages that they would otherwise be unable to read. TRIAL REGISTRATION NUMBER: PROSPERO 2017 CRD42017078797.
Assuntos
Panax , Análise do Sêmen , Sêmen/efeitos dos fármacos , Protocolos Clínicos , Humanos , Masculino , Revisões Sistemáticas como AssuntoRESUMO
BACKGROUND: The aim of this systematic review was to update, complete, and critically evaluate the evidence from placebo-controlled randomized clinical trials (RCTs) of ginseng for managing menopausal women's health. METHODS: We searched the literature using 13 databases (MEDLINE, AMED, EMBASE, the Cochrane Library, 6 Korean Medical, and 3 Chinese Databases) from their inception to July 2016 and included all double-blind RCTs that compared any type of ginseng with a placebo control in postmenopausal women. The methodological quality of all studies was assessed using a Cochrane risk of bias tool. RESULTS: Ten RCTs met our inclusion criteria. Most RCTs had unclear risk of bias. One RCT did not show a significant difference in hot flash frequency between Korean red ginseng (KRG) and placebo. The second RCT reported positive effects of KRG on menopausal symptoms. The third RCT found beneficial effects of ginseng (Ginsena) on depression, well-being, and general health. Four RCTs failed to show significant differences in various hormones between KRG and placebo controls except dehydroepiandrosterone. Two other RCTs failed to show effects of KRG on endometrial thickness in menopausal women. The other RCT also failed to show the effects of American ginseng on oxidative stress markers and other antioxidant enzymes. CONCLUSION: Our systematic review provided positive evidence of ginseng for sexual function and KRG for sexual arousal and total hot flashes score in menopausal women. However, the results of KRG or ginseng failed to show specific effects on hot flash frequency, hormones, biomarkers, or endometrial thickness. The level of evidence for these findings was low because of unclear risk of bias.
Assuntos
Terapias Complementares/métodos , Menopausa/efeitos dos fármacos , Panax/química , Fitoterapia , Extratos Vegetais/uso terapêutico , Saúde da Mulher , Terapias Complementares/efeitos adversos , Método Duplo-Cego , Feminino , Humanos , Qualidade de Vida , Ensaios Clínicos Controlados Aleatórios como Assunto , Resultado do TratamentoRESUMO
Danggui Shaoyao San (DSS), a traditional herbal prescription, has long been used to treat menopause-related symptoms, including dysmenorrhea. We conducted a systematic review of randomized controlled trials to evaluate the efficacy of DSS for dysmenorrhea. We searched the following electronic databases through October 2015: PubMed; EMBASE; the Cochrane Library; AMED; five Korean databases (KoreaMed, DBPIA, OASIS, RISS, and KISS); three Chinese databases (CNKI, Wan Fang Database, and VIP), and one Japanese database (CiNii). The Cochrane criteria were used to assess the risk of bias for the individual studies. All randomized clinical trials (RCTs) of DSS or modified DSS were included. Data from all articles were extracted by two independent reviewers. Meta-analysis was used to pool the data. A total of 746 potentially relevant studies were identified, and four RCTs met our inclusion criteria. All of the included RCTs had a high risk of bias across their domains. Three RCTs showed favourable effects of DSS on response rate compared with conventional medicine, and a meta-analysis showed that DSS had superior effects compared to analgesics (RR: 1.31, 95%CI, 1.06-1.63, I(2)=73%). One RCT showed a beneficial effect of DSS on pain compared with placebo control. Our systematic review and meta-analysis provided suggestive evidence of the superiority of DSS over analgesics or placebo for dysmenorrhea. The quality of evidence for this finding was low to moderate because of a high risk of bias.
Assuntos
Medicamentos de Ervas Chinesas/uso terapêutico , Dismenorreia/tratamento farmacológico , Fitoterapia , Analgésicos/uso terapêutico , Feminino , Humanos , Ensaios Clínicos Controlados Aleatórios como Assunto , Viés de SeleçãoRESUMO
The present study was conducted to investigate the effect of Sagunja-tang on the lipid related disease in a rat model of menopausal hyperlipidemia and lipid accumulation in methyl-ß-cyclodextrin-induced HepG2 cells. In in vivo study using menopausal hyperlipidemia rats, Sagunja-tang reduced retroperitoneal and perirenal fat, serum lipids, atherogenic index, cardiac risk factor, media thickness, and nonalcoholic steatohepatitis score, when compared to menopausal hyperlipidemia control rats. In HepG2 cells, Sagunja-tang significantly decreased the lipid accumulation, total cholesterol levels, and low-density/very-low-density lipoprotein levels. Moreover, Sagunja-tang reversed the methyl-ß-cyclodextrin-induced decrease in the protein levels of critical molecule involved in cholesterol synthesis, sterol regulatory element binding protein-2, and low-density lipoprotein receptor and inhibited protein levels of 3-hydroxy-3-methylglutaryl coenzyme A reductase as well as activity. Phosphorylation level of AMP-activated protein kinase was stimulated by Sagunja-tang. These results suggest that Sagunja-tang has effect on inhibiting hepatic lipid accumulation through regulation of cholesterol synthesis and AMPK activity in vitro. These observations support the idea that Sagunja-tang is bioavailable both in vivo and in vitro and could be developed as a preventive and therapeutic agent of hyperlipidemia in postmenopausal females.
RESUMO
Samul-tang (Si-Wu-Tang, SMT), a kind of herbal medicines, has been used for the hemato-deficient disease for hundreds of years. In this work, investigate the anti-anemia activity of the H2O extracts from constituent herbal medicines of Samul-tang in an anemia model induced by intravenous infection of phenylhydrazine-HCL (PHZ) at 10 mg/kg for 4 days. After PHZ injection, female Sparague-Dawley rats were administrated extracts from constituent herbal medicines of SMT (300 mg/kg/day, p.o.) daily for 1 week. Results showed that sever hemolysis was induced by PHZ. For Paeonia lactiflora (PL2) H2O extract treated groups, the concentration of hemoglobin, hematocrit and red blood cells number increased much more significantly than PHZ-treated group. Moreover, Angelica gigas (AG), Angelica. acutiloba (AA), Paeonia lactiflora (PL2) and Rehmannia glutinosa (RG) extract administration significantly improved serum erythropoietin concentration. The activity of aminolevulinic acid dehydrates (ALDL) in liver homegenate was increased in Angelica gigas(AA), Paeonia lactiflora (PL2) and Rehmannia glutinosa (RG) treated group.
Assuntos
Anemia Hemolítica/tratamento farmacológico , Medicamentos de Ervas Chinesas/farmacologia , Hematínicos/farmacologia , Hematopoese/efeitos dos fármacos , Fenil-Hidrazinas , Anemia Hemolítica/sangue , Anemia Hemolítica/induzido quimicamente , Animais , Biomarcadores/sangue , Modelos Animais de Doenças , Contagem de Eritrócitos , Eritrócitos/efeitos dos fármacos , Eritrócitos/metabolismo , Eritropoetina/sangue , Feminino , Hematócrito , Hemoglobinas/metabolismo , Humanos , Fígado/efeitos dos fármacos , Fígado/enzimologia , Fitoterapia , Plantas Medicinais , Sintase do Porfobilinogênio/metabolismo , Ratos Sprague-Dawley , Fatores de TempoRESUMO
OBJECTIVE: To elucidate the molecular mechanisms underlying the anti-inflammatory effects of Danggui Liuhuang Decoction () or Dangkwiyughwang-tang (DGLHT) water extract. METHODS: Effect of DGLHT on the lipopolysaccharide (LPS)-induced production of several pro-inflammatory mediators, including nitric oxide (NO), prostaglandin E(2) (PGE(2)), and interleukin-6 (IL-6) were examined by using enzymelinked immunosorbent assay. To determine the underlying mechanism of the inhibitory effects of DGLHT, the expression levels of inducible NO synthase (iNOS) and cyclooxygenase-2 (COX-2) protein, as well as iNOS, COX-2, and IL-6 mRNA levels were examined by Western blot and reverse transcription polymerase chain reaction (RT-PCR). Mitogen-activated protein kinases (MAPKs) in LPS-stimulated RAW 264.7 cells were also examined by Western blot. RESULTS: DGLHT inhibited LPS-induced production of NO, PGE(2), and IL-6 productions and the expressions of iNOS and COX-2. Furthermore, DGLHT suppressed LPS-induced phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2). CONCLUSIONS: DGLHT has inhibitory effects on the LPSinduced production of PGE(2), NO, and IL-6 and on the expressions of iNOS and COX-2 in murine macrophages. These anti-inflammatory effects occur through inhibition of MAPK phosphorylation.